Protagonist Therapeutics, Inc. Soared

Protagonist Therapeutics, Inc. (PTGX:NASDAQ) jumped higher at $14.2, representing a gain of 83.7%. The stock appeared on our News Catalysts scanner on Wed 15 Apr 20 at 09:21 PM in the 'PRIVATE PLACEMENT' category. From Thu 23 Apr 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Protagonist Therapeutics, Inc. (PTGX:NASDAQ)
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.
Top 10 Gainers:
- Fuel Tech, Inc. (FTEK:NASDAQ), 93.62%
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 83.7%
- Ocwen Financial Corporation (OCN:NYSE), 70.03%
- Superior Drilling Products, Inc. (SDPI:NYSEMKT), 56.14%
- Everspin Technologies, Inc. (MRAM:NASDAQ), 51.88%
- Natural Grocers by Vitamin Cottage, Inc. (NGVC:NYSE), 42.56%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 40.16%
- American Axle & Manufacturing Holdings, Inc. (AXL:NYSE), 39.91%
- Eastman Kodak Company (KODK:NYSE), 37.44%
- Peabody Energy Corporation (BTU:NYSE), 35.53%